Home > Oncology > COVID has led to a drop in lung cancer diagnosis, more deaths

COVID has led to a drop in lung cancer diagnosis, more deaths

Conference
IASLC World Conference on Lung Cancer
Reuters Health - 02/02/2021 - A study from Spain demonstrates the clear and significant negative impact the COVID-19 pandemic is having on lung cancer diagnosis and outcomes. "The COVID-19 pandemic is likely to last for a very long period of time, so we have to make a special effort for ensuring the cancer diagnosis and treatment of our patients," Dr. Roxana Reyes said during a press briefing at International Association for the Study of Lung Cancer (IASLC) virtual World Conference on Lung Cancer (WCLC). Dr. Reyes, with the Thoracic Oncology Group at the Hospital Clinic de Barcelona, and colleagues, analyzed data of new cases of lung cancer diagnosed in from January to June 2019 (pre-COVID) and the same time frame one year later during COVID-19. They found that 100 of the 162 patients with newly-diagnosed lung cancer were diagnosed in the pre-COVID period (62 during COVID) - a 38% decline in new lung cancer diagnoses during the pandemic. By histologic ...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on